Over several years, Cecilia was bounced from doctor to doctor until she found someone who finally listened to her concerns and properly diagnosed her with primary biliary cholangitis (#PBC). Ensuring patient voices are heard and understood is a critical aspect of healthcare, and especially important when diagnosing and managing #rarediseases. Watch Cecilia recount her experience with PBC.
Intercept Pharmaceuticals
制药业
Morristown，New Jersey 65,542 位关注者
Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
关于我们
We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is located in New Jersey. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma.
- 网站
-
https://www.interceptpharma.com
Intercept Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Morristown，New Jersey
- 类型
- 上市公司
- 创立
- 2002
- 领域
- Non-viral Liver Diseases、Rare Diseases、Biotechnology和Innovation
地点
Intercept Pharmaceuticals员工
-
Janet Lewis
-
William Wallace
Chief Information Officer | VP IT | Biotech | Pharmaceuticals | Cyber-Security | Team Building | Global Business Focus | AI Evangelist | MBA in…
-
Grady Mateen
Rare Disease Therapeutic Business Specialist at Intercept Pharmaceuticals | 20+ years in the Pharmaceutical Industry | Territory Turnaround…
-
Arash Thranian, PhD., MBA
Director, Field Medical, Medical Science Liaison at Intercept Pharmaceuticals
动态
-
March is #WomensHistoryMonth! Let’s celebrate the women who are paving the way for the leaders of tomorrow. Take a moment to celebrate a woman in your life who has made a meaningful impact on others. Learn more: bit.ly/2BlI5Or ?
-
-
In celebration of #BlackHistoryMonth, Blended, our company's BIPOC Employee Resource Group, hosted a virtual visit for our employee team with Hepatologist, Researcher, and Duke University School of Medicine Associate Professor Julius Wilder. We greatly appreciate Dr. Wilder taking time to share with us eye-opening insights on health disparities, the social drivers of health in gastroenterology and hepatology, and the importance of representation.?
-
-
We’re excited to celebrate another #RareDiseaseDay with National Organization for Rare Disorders! This year’s theme is “More Than You Can Imagine.” It reminds us there is still more awareness, research and advocacy work to be done. Learn how you can join us in making a difference: https://bit.ly/3CzIjmN
-
-
In honor of #BlackHistoryMonth, we spoke with our very own Yvonne Evelyn, MS HRM, about the importance of recognizing this month.
-
-
This #NationalCaregiversDay, we’d like to thank our caregivers in the liver community for their unwavering dedication and support for individuals living with rare and serious liver diseases, like primary biliary cholangitis (#PBC). Thank you for all that you do!?
-
-
Did you know that for those living with primary biliary cholangitis (#PBC), untreated conditions can lead to liver failure and potentially a liver transplant? Learn more about #NationalDonorDay: https://bit.ly/2N5YoCV?
-
-
February marks Rare Liver Diseases Month, led by the Global Liver Institute, which aims to raise awareness for rare liver conditions leading up to #RareDiseaseDay on February 28. Join us in supporting those affected by rare and serious liver diseases, like primary biliary cholangitis (#PBC)!?
-
-
#HappyNewYear from Intercept!?We hope your #2025 is filled with joy, health and new adventures!?
-